Xingya Guo

902 total citations · 1 hit paper
14 papers, 660 citations indexed

About

Xingya Guo is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Xingya Guo has authored 14 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Xingya Guo's work include Circular RNAs in diseases (6 papers), Cancer-related molecular mechanisms research (5 papers) and MicroRNA in disease regulation (5 papers). Xingya Guo is often cited by papers focused on Circular RNAs in diseases (6 papers), Cancer-related molecular mechanisms research (5 papers) and MicroRNA in disease regulation (5 papers). Xingya Guo collaborates with scholars based in China and United States. Xingya Guo's co-authors include Qin Pan, Weiliang Jiang, Wenqin Xiao, Jian‐Gao Fan, Rong Wan, Yinshi Huang, Yangyang Hu, Yun Feng, Kai Li and Fang Sun and has published in prestigious journals such as Science Translational Medicine, Experimental Cell Research and Molecular Cancer.

In The Last Decade

Xingya Guo

14 papers receiving 658 citations

Hit Papers

RNA demethylase ALKBH5 prevents pancreatic cancer progres... 2020 2026 2022 2024 2020 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner
    2020 285 citations Xingya Guo, Kai Li et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xingya Guo China 9 583 404 88 61 39 14 660
Julia Ramírez-Moya Spain 6 788 1.4× 410 1.0× 27 0.3× 40 0.7× 32 0.8× 8 852
Jialin Su China 10 372 0.6× 158 0.4× 16 0.2× 32 0.5× 42 1.1× 30 467
Guofu Huang China 13 420 0.7× 230 0.6× 39 0.4× 67 1.1× 13 0.3× 20 526
Hee Kyu Lee South Korea 9 315 0.5× 138 0.3× 136 1.5× 89 1.5× 18 0.5× 9 477
Ping Pang China 9 310 0.5× 133 0.3× 16 0.2× 27 0.4× 53 1.4× 18 377
Haiou Hong China 5 398 0.7× 195 0.5× 46 0.5× 19 0.3× 67 1.7× 10 459
Hai‐Yu Mo China 9 350 0.6× 239 0.6× 17 0.2× 95 1.6× 28 0.7× 13 513
Liang Chang China 13 399 0.7× 346 0.9× 33 0.4× 42 0.7× 27 0.7× 21 478

Countries citing papers authored by Xingya Guo

Since Specialization
Citations

This map shows the geographic impact of Xingya Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingya Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingya Guo more than expected).

Fields of papers citing papers by Xingya Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingya Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingya Guo. The network helps show where Xingya Guo may publish in the future.

Co-authorship network of co-authors of Xingya Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Xingya Guo. A scholar is included among the top collaborators of Xingya Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingya Guo. Xingya Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Wang, Xing, Xingya Guo, Qiuyan Zhao, et al.. (2023). NAT10-mediated AXL mRNA N4-acetylcytidine modification promotes pancreatic carcinoma progression. Experimental Cell Research. 428(2). 113620–113620. 29 indexed citations
2.
3.
Wan, Rong, Wenqin Xiao, Weiliang Jiang, et al.. (2023). Fenbufen Alleviates Severe Acute Pancreatitis by SuppressingCaspase-1/Caspase-11-mediated Pyroptosis in Mice. Current Molecular Pharmacology. 17. e110523216783–e110523216783. 4 indexed citations
4.
Zhao, Qiuyan, Zhonglin Zhu, Wenqin Xiao, et al.. (2022). Hypoxia-induced circRNF13 promotes the progression and glycolysis of pancreatic cancer. Experimental & Molecular Medicine. 54(11). 1940–1954. 26 indexed citations
5.
6.
Jiang, Weiliang, Dapeng Ju, Zhanjun Lu, et al.. (2022). The pancreatic clock is a key determinant of pancreatic fibrosis progression and exocrine dysfunction. Science Translational Medicine. 14(664). eabn3586–eabn3586. 25 indexed citations
7.
Guo, Xingya, Kai Li, Weiliang Jiang, et al.. (2020). RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner. Molecular Cancer. 19(1). 91–91. 285 indexed citations breakdown →
8.
Li, Sisi, Weiliang Jiang, Wenqin Xiao, et al.. (2019). KMT2D deficiency enhances the anti-cancer activity of L48H37 in pancreatic ductal adenocarcinoma. World Journal of Gastrointestinal Oncology. 11(8). 599–621. 20 indexed citations
9.
Hu, Yangyang, Juanjuan Dai, Jingbo Xiao, et al.. (2019). Restoration of p53 acetylation by HDAC inhibition permits the necrosis/apoptosis switch of pancreatic ainar cell during experimental pancreatitis in mice. Journal of Cellular Physiology. 234(12). 21988–21998. 5 indexed citations
10.
Guo, Xingya, et al.. (2018). circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling. World Journal of Gastroenterology. 24(3). 323–337. 83 indexed citations
11.
Feng, Yun, Yuwei Dong, Junhua Xiao, et al.. (2018). MicroRNA‑449a is a potential predictor of colitis‑associated colorectal cancer progression. Oncology Reports. 40(3). 1684–1694. 17 indexed citations
12.
Sun, Fang, Xingya Guo, Jinzhi Wang, Yuqin Wang, & Qin Pan. (2018). Hepatic Stellate Cells Inhibit Epithelial-to-Mesenchymal Transition of Hepatoma Cells: Effect of MiR-233 Modification on Exosomes. Nanoscience and Nanotechnology Letters. 10(11). 1546–1553. 1 indexed citations
13.
Guo, Xingya, et al.. (2017). circRNA_0046367 Prevents Hepatoxicity of Lipid Peroxidation: An Inhibitory Role against Hepatic Steatosis. Oxidative Medicine and Cellular Longevity. 2017(1). 3960197–3960197. 95 indexed citations
14.
Guo, Xingya, et al.. (2017). Circular RNA Profiling and Bioinformatic Modeling Identify Its Regulatory Role in Hepatic Steatosis. BioMed Research International. 2017. 1–13. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julia Ramírez-Moya Breakdown of academic impact, for papers by Jialin Su Breakdown of academic impact, for papers by Guofu Huang Breakdown of academic impact, for papers by Hee Kyu Lee Breakdown of academic impact, for papers by Ping Pang Breakdown of academic impact, for papers by Haiou Hong Breakdown of academic impact, for papers by Hai‐Yu Mo Breakdown of academic impact, for papers by Liang Chang
Rankless by CCL
2026